Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots

* Able to understand and sign informed consent.

* Able to complete study and comply with study procedures.

* Caucasian female ages 25-55.

* Presence of photodamage and lentigines of II-III on the Glogau Photoaging

* Must be willing to avoid laser and light treatments, treatments with filler, chemical peels, microdermabrasion, Botox or any other cosmetic treatment to the face during the duration of the study.

* Must be willing to avoid changing topical moisturizers and cosmetics during the study.

* Able to stop any alpha or beta hydroxy acids, topical retinol or retinoid derivatives, topical antioxidants, or any topical product that may interfere with the study 2 weeks prior to the study.

* Cosmetic treatment of face, such as laser or light treatment, filler, Botox, microdermabrasion, or chemical peels 6 months prior to study or during study.

* Current smoker.

* Pregnant, nursing, or planning to become pregnant during study.

* Currently taking drugs including oral retinoids or any other medication with a known clinically significant drug interaction with topical tretinoin.

* Known hypersensitivity to retinoids. History of severe retinoid dermatitis.

* History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study.

* Concurrent participation in another clinical study or participation 30 days prior to enrollment that includes exposure to an investigational drug that would interfere with this study.

* Any disease or condition which would interfere with study participation or unduly increase risk.

* Presence of an electrically sensitive support system such as a pacemaker.

* Known history of epilepsy.

* Presence of metal implants or metal braces on teeth.